logo-loader

MGC Pharmaceuticals to reveal medicinal cannabis next steps

Published: 08:30 10 Feb 2017 AEDT

Marijuana-667836_1920_589ce9a18de68
MGC Pharmaceuticals to update on agreement

MGC Pharmaceuticals (ASX:MXC) has been granted a trading halt by the ASX, pending details in relation to a binding agreement regarding commencement of Slovenian epilepsy clinical tests with medicinal cannabis.

The halt will remain in place until the opening of trade on Tuesday 14th February 2017, or earlier if an announcement is made to the market.

MGC Pharmaceuticals reveals strategic objectives for H1 2024

MGC Pharmaceuticals Ltd (LSE:MXC, OTC:MGCLF, ASX:MXC) CEO and Managing Director Roby Zomer speaks to Thomas Warner from Proactive London following the completion of a share consolidation and capital raise. With these restructuring initiatives completed, Zomer shares his enthusiasm for the...

on 14/11/23